🇺🇸 FDA
Patent

US 7300915

Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

granted A61KA61K38/1816

Quick answer

US patent 7300915 (Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain) held by The Regents of the University of California expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/1816